Drug Chatter -- Tracking biopharma stock chatter

Profile for Imprimis Pharmaceuticals, Inc. (IMMY)

« Back to company index

IMMY Chatter Timeline

Stock Ticker for IMMY

Most Active Tweeters for IMMY

UserTweets
@jgrim375 4
@storminvestor 4
@ShockExchange 4
@SPNewsAnalysis 2
@markbaum4 2

Recent Tweets for IMMY

storminvestor @storminvestor
Somewhat Positive Press Coverage Somewhat Unlikely to Affect Imprimis Pharmaceuticals $IMMY Stock Price https://t.co/O2DzJYJC97
12:09am
CFinancialNews @CFinancialNews
Critical Contrast: Prothena Corporation PLC $PRTA & Imprimis Pharmaceuticals $IMMY https://t.co/vqwZaVu0vm
September 25th 2017, 9:09am
WatchlistN @WatchlistN
Critical Contrast: Prothena Corporation PLC $PRTA & Imprimis Pharmaceuticals $IMMY https://t.co/MkCDDjO8uV
September 25th 2017, 8:09am
intercooleronli @intercooleronli
Critical Contrast: Prothena Corporation PLC $PRTA & Imprimis Pharmaceuticals $IMMY https://t.co/GgHH6e6VQD
September 25th 2017, 8:09am
Mia__YuupXo @Mia__YuupXo
RT @marketexclusive: IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8-K Other Events https://t.co/At08VFzOKZ $IMMY
September 21st 2017, 9:09am
ShockExchange @ShockExchange
$AGN Sues Another Restasis Competitor. Where's #SherrodBrown ? https://t.co/Dxd98jdcOK $IMMY @Joeschmo3311 @JTSEO9… https://t.co/D8ybOWKiWA
September 21st 2017, 8:09am
QLFilings @QLFilings
$IMMY filed Form 8-K with the SEC. Most mentioned words: eton, product, fda, market, letter
September 21st 2017, 8:09am
confcalltran @confcalltran
OnSeptember https://t.co/qvp8ElRU76 $IMMY
September 21st 2017, 8:09am
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/hrBTNT7Tbc
September 21st 2017, 8:09am
marketexclusive @marketexclusive
IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8-K Other Events https://t.co/At08VFzOKZ $IMMY
September 21st 2017, 8:09am
deepxdive @deepxdive
$IMMY Imprimis Pharmaceuticals, Inc. IMMY-US Earnings Analysis Q2, 2017 By the Numbers September 20, 2017… https://t.co/zybqcGtX4S
September 20th 2017, 1:09pm
OTC_U_Know_Me @OTC_U_Know_Me
$IMMY |on watch @ $1.67 https://t.co/50oti6qFFV via @Barchart
September 20th 2017, 12:09pm
ShockExchange @ShockExchange
RT @SeekingAlpha: https://t.co/L92Cl29Zv2 $IMMY $AGN
September 20th 2017, 4:09am
SeekingAlpha @SeekingAlpha
https://t.co/L92Cl29Zv2 $IMMY $AGN
September 20th 2017, 4:09am
storminvestor @storminvestor
Imprimis Pharmaceuticals $IMMY Earns Daily News Impact Rating of 0.00 https://t.co/GrNAlKhGEZ
September 19th 2017, 9:09pm
TranscriptDaily @TranscriptDaily
MyoKardia $MYOK & Imprimis Pharmaceuticals $IMMY Head-To-Head Survey https://t.co/1dEeOCYBbs
September 19th 2017, 7:09pm
jgrim375 @jgrim375
RT @markbaum4: Dearth of $AGN ophth innovation; dry eye patent nonsense; $IMMY's Surface Pharma coming to help dry eye patients ... https:/…
September 19th 2017, 7:09pm
jgrim375 @jgrim375
Surgeons address need for payment strategy for drop therapy alternative https://t.co/q2nRUMZI5J $immy
September 19th 2017, 5:09pm
ShockExchange @ShockExchange
@markbaum4 SE Agrees. $AGN 's Spat With $IMMY Is Ruse To Protect [i] Restasis [ii] Inflated Stock >… https://t.co/yuL0EIFPOG
September 19th 2017, 1:09pm
markbaum4 @markbaum4
Dearth of $AGN ophth innovation; dry eye patent nonsense; $IMMY's Surface Pharma coming to help dry eye patients ... https://t.co/PgE4h4M9Gk
September 19th 2017, 1:09pm
StockTipRobot @StockTipRobot
A series of technical analyses and random guesses suggest you rethink your position in Imprimis Pharmaceuticals $IMMY #StockMarket
September 18th 2017, 4:09pm
Ryq9xM7CX14o2kf @Ryq9xM7CX14o2kf
RT @CNNMoney: How one CEO is fighting back against 'absurd' drug price hikes https://t.co/O2OVMKhKFO @ACPinternists $IMMY https://t.co/DwrD…
September 17th 2017, 12:09pm
WatchlistN @WatchlistN
Analyzing MyoKardia $MYOK & Imprimis Pharmaceuticals $IMMY https://t.co/72LrHjy1tq
September 17th 2017, 12:09pm
SleekMoneycom @SleekMoneycom
Analyzing MyoKardia $MYOK & Imprimis Pharmaceuticals $IMMY https://t.co/5dEEXOGepp
September 17th 2017, 12:09pm
stocknewstimes @stocknewstimes
Analyzing MyoKardia $MYOK & Imprimis Pharmaceuticals $IMMY https://t.co/3NyLabpqC7
September 17th 2017, 12:09pm
storminvestor @storminvestor
Imprimis Pharmaceuticals $IMMY & MyoKardia $MYOK Head-To-Head Survey https://t.co/bDHPbeKfwb
September 15th 2017, 5:09am
SPNewsAnalysis @SPNewsAnalysis
Imprimis Pharmaceuticals $IMMY & MyoKardia $MYOK Head-To-Head Survey https://t.co/0nBpIfGiMu
September 15th 2017, 4:09am
pharma_sector @pharma_sector
FDA Curcumin Investigation Supports #Imprimis Statement . Read more: https://t.co/VTVMai3kDz $IMMY
September 14th 2017, 4:09pm
SEEKINGALPHA_FS @SEEKINGALPHA_FS
FDA inquiry into mislabeling of castor oil confirms statements by Imprimis Pharma; shares ahead 2% https://t.co/VtRRK8VFrK $IMMY
September 14th 2017, 11:09am
MarketCurrents @MarketCurrents
FDA inquiry into mislabeling of castor oil confirms statements by Imprimis Pharma; shares ahead 2% https://t.co/WMBFQ6Ozgt $IMMY
September 14th 2017, 11:09am
vince_falvo @vince_falvo
$IMMY I don't think this is understood yet https://t.co/qKjFimRCfa
September 14th 2017, 10:09am
Briefingcom @Briefingcom
$IMMY: Imprimis Pharmaceuticals updates on previously-announced FDA MedWatch notice https://t.co/N3hXO2Rh9H
September 14th 2017, 10:09am
markbaum4 @markbaum4
#FDA Curcumin Investigat Supports $IMMY Stmt; competition not happy; 1,700+ customers happy; focus on profitability https://t.co/EmpWISgXty
September 14th 2017, 9:09am
jgrim375 @jgrim375
RT @WizAtWallSt: $IMMY FDA Curcumin Investigation Supports Imprimis Statement that an Issue was Caused by a Supplier's Mislabeling
September 14th 2017, 8:09am
StockNewsWires @StockNewsWires
$IMMY: Imprimis Pharma (IMMY) Says FDA Curcumin Investigation Supports …: https://t.co/IUuWwklj66
September 14th 2017, 8:09am
WizAtWallSt @WizAtWallSt
$IMMY FDA Curcumin Investigation Supports Imprimis Statement that an Issue was Caused by a Supplier's Mislabeling
September 14th 2017, 8:09am
storminvestor @storminvestor
Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Imprimis Pharmaceuticals $IMMY Stock Price https://t.co/HXAOth1d3k
September 13th 2017, 9:09pm
WeekHerald @WeekHerald
Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Imprimis Pharmaceuticals $IMMY Stock Price https://t.co/Tkt8qNqk5O
September 13th 2017, 9:09pm
SPNewsAnalysis @SPNewsAnalysis
Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Imprimis Pharmaceuticals $IMMY Stock Price https://t.co/ZhbF2VjVxb
September 13th 2017, 9:09pm
jgrim375 @jgrim375
RT @zipjet: Long ago I took a course in "unfair competition". Most of it long forgotten. It is amusing that $IMMY is being unfair to $AGN…
September 12th 2017, 10:09pm
zipjet @zipjet
Long ago I took a course in "unfair competition". Most of it long forgotten. It is amusing that $IMMY is being un… https://t.co/yMeO90R6EW
September 12th 2017, 12:09pm
ShockExchange @ShockExchange
RT @zipjet: If I ran $AGN given the competition $IMMY is fielding, and legal said we could stomp you out of existence or damage you, I'd sa…
September 12th 2017, 11:09am
zipjet @zipjet
If I ran $AGN given the competition $IMMY is fielding, and legal said we could stomp you out of existence or damage… https://t.co/3au8O9XP4t
September 12th 2017, 11:09am
NaturoDiaries @NaturoDiaries
To be fair, $IMMY does sell dubious compounded products for injection that are used in "integrative medicine."… https://t.co/v8vdVguJj7
September 12th 2017, 3:09am
NASDAQODUK @NASDAQODUK
$IMMY Imprimis Releases Statement Regarding Allergan Lawsuit… https://t.co/kDLQejEnej
September 11th 2017, 8:09pm
SarahsDDNews @SarahsDDNews
@NaturoDiaries $IMMY CEO says #FDA has 'on-again, off-again embrace of compounding' - the #regulatory space for the… https://t.co/bBHhWjRgu2
September 11th 2017, 1:09pm
NaturoDiaries @NaturoDiaries
RT @SarahsDDNews: $AGN alleges $IMMY makes, sells and promotes unapproved drugs – and Imprimis fires back. https://t.co/27dauFSAQG
September 11th 2017, 12:09pm
NaturoDiaries @NaturoDiaries
@SarahsDDNews $IMMY does sell a whole lot of dubious compounded substances that appear to be marketed as drugs.
September 11th 2017, 12:09pm
SarahsDDNews @SarahsDDNews
$AGN alleges $IMMY makes, sells and promotes unapproved drugs – and Imprimis fires back. https://t.co/27dauFSAQG
September 11th 2017, 10:09am
DrugDeliveryNow @DrugDeliveryNow
#Allergan alleges Imprimis makes, sells and promotes unapproved drugs – and Imprimis fires back. $AGN $IMMY https://t.co/Ccwrd9YAo5
September 11th 2017, 10:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.